The diagnosis of “secondary progressive MS” has long been thought to mark a shift in the course of the disease from a primarily inflammatory process to a neurodegenerative one. Although the majority of people with…
Read More
You're Reading:
About the Author
This content was compiled by Rocky Mountain MS Center staff members.
More From This Issue:
InforMS: Winter 2025
MS Research Today: Expanding Horizons
From new treatment targets and trial designs to broader inclusion and predictive biomarkers, MS research is entering a new era focused on progression, precision, and quality of life. For...
InforMS: Winter 2025
Remembering Patricia Daily
We are deeply saddened to share the news of the passing of our colleague and friend, Patricia Daily. Many in our community knew Pat, worked alongside her, or benefited from...
InforMS: Winter 2025
BTK Inhibitors: A New Class Focused on Progression
A research emphasis on measuring relapses and tracking MRIs naturally leads to a treatment emphasis on preventing relapses and reducing MRI activity. And of course, both are still important. But...
InforMS: Winter 2025
Lifestyle and Brain Health: What You Can Influence
One encouraging thread across recent studies is how daily habits can build cognitive reserve — the brain’s ability to work around damage — while also improving mood, sleep, and physical...
InforMS: Winter 2025
The Evolving Research of Discontinuing DMTs
One of the most common topics that comes up in RMMSC education programs and Q&A sessions is the question of discontinuing disease-modifying therapies (DMTs). Patients want to know when they...
InforMS: Winter 2025
Moving the Needle: One Participant’s Journey Through MS Research
For this issue of InforMS, we sat down with David Dombeck, a research participant at the Rocky Mountain MS Center at the University of Colorado. David was diagnosed later in...
InforMS: Winter 2025
Investing in Innovation: How Grassroots Research Funding Turns Bold Ideas into Better Care
Meaningful progress in multiple sclerosis research often begins with a single question. But those questions may not always fit the requirements of large federal or medical industry grants. Research that...
ADVERTISEMENT
